Laurence Lejeune

Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice

Nicoletta Eliopoulos, John Stagg, Laurence Lejeune et al. · Blood · 2005 · 552 citations

Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo

A. Alkhaldi, Nicoletta Eliopoulos, Daniel Martineau et al. · Gene Therapy · 2003 · 204 citations

Regenerative Medicine, Developmental Biology, Angiogenesis +6

Marrow Stromal Cells for Interleukin-2 Delivery in Cancer Immunotherapy

John Stagg, Laurence Lejeune, André Paquin et al. · Human Gene Therapy · 2004 · 106 citations

Marrow Stromal Cells, Cell Therapy, Cancer Immunosurveillance +15

Cooperation of Matrix Metalloproteinases with the RhoA/Rho Kinase and Mitogen‐Activated Protein Kinase Kinase‐1/Extracellular Signal‐Regulated Kinase Signaling Pathways Is Required for the Sphingosine‐1‐Phosphate‐Induced Mobilization of Marrow‐Derived Stromal Cells

Mayya Mériane, Stéphanie Duhamel, Laurence Lejeune et al. · Stem Cells · 2006 · 77 citations · Full text

Immunology, Cellular Physiology, Regenerative Medicine +22

CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization

Ian B. Copland, Kapil Sharma, Laurence Lejeune et al. · Experimental Hematology · 2007 · 51 citations

Regenerative Medicine, Cell Therapy, Medicine +11